The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Abstract
Improved in vitro systems for predicting drug-induced toxicity are needed in the pharmaceutical and biotechnology industries to decrease late-stage drug attrition. One unmet need is an early screen for cardiotoxicity, which accounts for about one third of safety-based withdrawn pharmaceuticals. Herein, the first published report of a high-throughput functional assay employing a monolayer of beating human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is described, detailing a model that accurately detects drug-induced cardiac abnormalities. Using 96-well plates with interdigitated electrode arrays that assess impedance, the rhythmic, synchronous contractions of the iPSC-CMs were detected. Treatment of the iPSC-CMs with 28 different compounds with known cardiac effects resulted in compound-specific changes in the beat rate and/or the amplitude of the impedance measurement. Changes in impedance for the compounds tested were comparable with the results from a related technology, electric field potential assessment obtained from microelectrode arrays. Using the results from the set of compounds, an index of drug-induced arrhythmias was calculated, enabling the determination of a drug's proarrhythmic potential. This system of interrogating human cardiac function in vitro opens new opportunities for predicting cardiac toxicity and studying cardiac biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
A morphological biosensor for mammalian cells
Giaever, I., & Keese, C. R. (1993) · Nature · doi:10.1038/366591a0 · Cited by 770
Chan, T. Y. K. (2009) · Clinical Toxicology · doi:10.1080/15563650902904407 · Cited by 398
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., & Mummery, C. L. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.11.004 · Cited by 368
Physiology and pharmacology of the cardiac pacemaker (“funny”) current
Baruscotti, M., Bucchi, A., & DiFrancesco, D. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.005 · Cited by 338
Ponti, F. D., Poluzzi, E., Cavalli, A., Recanatini, M., & Montanaro, N. (2002) · Drug Safety · doi:10.2165/00002018-200225040-00004 · Cited by 309
HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine
Roy, M.-L., Dumaine, R., & Brown, A. M. (1996) · Circulation · doi:10.1161/01.cir.94.4.817 · Cited by 303
Use and Application of Stem Cells in Toxicology
Davila, J. C. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh100 · Cited by 281
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
Cao, F., Wagner, R. A., Wilson, K. D., Xie, X., Fu, J.-D., Drukker, M., Lee, A., Li, R. A., Gambhir, S. S., Weissman, I. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003474 · Cited by 234
Frothingham, R. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.20.1468.34482 · Cited by 208
The application of cell‐based label‐free technology in drug discovery
Xi, B., Yu, N., Wang, X., Xu, X., & Abassi, Y. (2008) · Biotechnology Journal · doi:10.1002/biot.200800020 · Cited by 184
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Peng, S., Lacerda, A. E., Kirsch, G. E., Brown, A. M., & Bruening-Wright, A. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.01.014 · Cited by 183
Martin, R. L., McDermott, J. S., Salmen, H. J., Palmatier, J., Cox, B. F., & Gintant, G. A. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200403000-00007 · Cited by 178
iPS cells: A source of cardiac regeneration
Yoshida, Y., & Yamanaka, S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.026 · Cited by 171
Global Expression Profile of Highly Enriched Cardiomyocytes Derived from Human Embryonic Stem Cells
Xu, X. Q., Soo, S. Y., Sun, W., & Zweigerdt, R. (2009) · Stem Cells · doi:10.1002/stem.166 · Cited by 164
Calcium and Cardiac Arrhythmias: DADs, EADs, and Alternans
Clusin, W. T. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609356 · Cited by 162
Nonclinical proarrhythmia models: Predicting Torsades de Pointes
Lawrence, C., Pollard, C. E., Hammond, T. G., & Valentin, J. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.04.011 · Cited by 126
Antimicrobials and the Risk of Torsades de Pointes
Poluzzi, E., Raschi, E., Motola, D., Moretti, U., & Ponti, F. D. (2010) · Drug Safety · doi:10.2165/11531850-000000000-00000 · Cited by 123
Crumb, W., Ekins, S., Sarazan, R. D., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0070-7 · Cited by 92
Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism
Lacerda, A. E., Kuryshev, Y. A., Chen, Y., Renganathan, M., Eng, H. F., Danthi, S. J., Kramer, J., Yang, T., & Brown, A. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128405 · Cited by 91
Lawrence, C., Bridgland-Taylor, M. H., Pollard, C. E., Hammond, T. G., & Valentin, J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706894 · Cited by 90
Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs
Hescheler, J., Halbach, M., Egert, U., et al. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2004.08.034 · Cited by 78
Clinical assessment of drug-induced QT prolongation in association with heart rate changes
Extramiana, F., Maison‐Blanche, P., CABANIS, M., Ortemann‐Renon, C., Beaufils, P., & Leenhardt, A. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.016 · Cited by 68
Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
Jonsson, M. K. B., Duker, G., Tropp, C., Andersson, B., Sartipy, P., Vos, M. A., & van Veen, T. A. B. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.02.001 · Cited by 65
Terfenadine Blocks Time-Dependent Ca2+, Na+, and K+ Channels in Guinea Pig Ventricular Myocytes
Ming, Z., & Nordin, C. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199511000-00013 · Cited by 62
In vitro models of proarrhythmia
Lawrence, C., Pollard, C. E., Hammond, T. G., & Valentin, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.195 · Cited by 59
Meyer, T. S., Leisgen, C., Gonser, B., & Günther, E. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.507 · Cited by 52
Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research
Kattman, S. J., Koonce, C. H., Swanson, B. J., & Anson, B. D. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9235-1 · Cited by 50
Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels
Demiryürek, A. T., & Demiryürek, Ş. (2005) · Autonomic and Autacoid Pharmacology · doi:10.1111/j.1474-8673.2004.00334.x · Cited by 50
Translational Prospects for Human Induced Pluripotent Stem Cells
CSETE, M. E. (2010) · Regenerative Medicine · doi:10.2217/rme.10.39 · Cited by 46
Antiarrhythmic and Proarrhythmic Properties of QT-Prolonging Antianginal Drugs
Singh, B. N., & Wadhani, N. (2004) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840400900107 · Cited by 40
Sager, P. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.222 · Cited by 38
Hove‐Madsen, L., Llach, A., Molina, C. E., Prat‐Vidal, C., Farré, J., Roura, S., & Juan Cinca, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.023 · Cited by 31
Bhandari, B., & Subramanian, L. (2007) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/157489007779606095 · Cited by 29
Lack of Action Potential-Prolonging Effect of Terfenadine on Rabbit Myocardial Tissue Preparations
Masumiya, H., Saito, M., Ito, M., Matsuda, T., Noguchi, K., Iida‐Tanaka, N., Tanaka, H., & Shigenobu, K. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.131 · Cited by 25
Ju, Y., Saint, D. A., & Gage, P. W. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050079 · Cited by 24
Cited by
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 519
Microfluidic heart on a chip for higher throughput pharmacological studies
Agarwal, A., Goss, J. A., Cho, A., McCain, M. L., & Parker, K. K. (2013) · Lab on a Chip · doi:10.1039/c3lc50350j · Cited by 494
iPS cells: a game changer for future medicine
Inoue, H., Nagata, N., Kurokawa, H., & Yamanaka, S. (2014) · The EMBO Journal · doi:10.1002/embj.201387098 · Cited by 405
Navarrete, E. G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P. W., Patlolla, B., Lee, A. S., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000570 · Cited by 302
Metadata
- Authors
- Guo, L., Abrams, R. M. C., Babiarz, J. E., Cohen, J. D., Kameoka, S., Sanders, M. J., Chiao, E., & Kolaja, K. L.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-20
- Volume
- 123
- Issue
- 1
- Pages
- 281-289
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2139658905
- Cited by
- 272
- References
- 38
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.